View in EDS

Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma.

Saved in:
Bibliographic Details
Title: Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma.
Authors: Capone E; Department of Innovative Technologies in Medicine & Dentistry, University 'G. D'Annunzio' of Chieti-Pescara, Chieti, Italy; Center for Advanced Studies and Technology (CAST), University 'G.D'Annunzio' of Chieti-Pescara, Chieti, Italy., Perrotti V; Department of Medical, Oral and Biotechnological Sciences, University 'G. d'Annunzio' Chieti-Pescara, Chieti, Italy; UdA-TechLab, Research Center, University 'G. d'Annunzio' of Chieti-Pescara, 66100 Chieti, Italy., Cela I; Department of Innovative Technologies in Medicine & Dentistry, University 'G. D'Annunzio' of Chieti-Pescara, Chieti, Italy; Center for Advanced Studies and Technology (CAST), University 'G.D'Annunzio' of Chieti-Pescara, Chieti, Italy., Lattanzio R; Department of Innovative Technologies in Medicine & Dentistry, University 'G. D'Annunzio' of Chieti-Pescara, Chieti, Italy; Center for Advanced Studies and Technology (CAST), University 'G.D'Annunzio' of Chieti-Pescara, Chieti, Italy., Togni L; Department of Biomedical, Sciences and Public Health, Marche Polytechnic University, Ancona, Italy., Rubini C; Department of Biomedical, Sciences and Public Health, Marche Polytechnic University, Ancona, Italy., Caponio VCA; Department of Clinical and Experimental Medicine, Foggia University, Foggia, Italy., Lo Muzio L; Department of Clinical and Experimental Medicine, Foggia University, Foggia, Italy., Colasante M; Department of Life, Health and Environmental Sciences, University of L'Aquila, Coppito, Italy., Giansanti F; Department of Life, Health and Environmental Sciences, University of L'Aquila, Coppito, Italy., Ippoliti R; Department of Life, Health and Environmental Sciences, University of L'Aquila, Coppito, Italy., Iacobelli S; MediaPharma s.r.l., Via Colonnetta 50/A, Chieti, Italy., Wick MJ; XenoSTART, San Antonio, TX, USA., Spardy Burr N; Adenoid Cystic Carcinoma Research Foundation (ACCRF), Needham, MA, USA., Sala G; Department of Innovative Technologies in Medicine & Dentistry, University 'G. D'Annunzio' of Chieti-Pescara, Chieti, Italy; Center for Advanced Studies and Technology (CAST), University 'G.D'Annunzio' of Chieti-Pescara, Chieti, Italy. Electronic address: g.sala@unich.it.
Source: Oral oncology [Oral Oncol] 2024 Jan; Vol. 148, pp. 106635. Date of Electronic Publication: 2023 Nov 21.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0593
DOI:10.1016/j.oraloncology.2023.106635